𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combination of oral idarubicin and prednimustine in advanced breast cancer: a phase II study

✍ Scribed by A. Barnadas; C. Mendiola; A. Casado; A. Villar; J. Jimeno; M. Clerigue; R. Rosell; E. Diaz-rubio; H. Cortés-funes; M.Garcia De Paredes


Book ID
117663629
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
390 KB
Volume
33
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


A phase II study of oral idarubicin (4-d
✍ Nicholas S. A. Stuart; Michael H. Cullen; Terrence J. Priestman; George R. P. Bl 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 352 KB

Idarubicin (4-demethoxydaunorubicin: DMDNR) is an orally active analogue of daunorubicin that has shown promising activity in animal and early clinical studies. We gave idarubicin in a phase II study to patients with advanced breast cancer unresponsive to hormonal manipulation and in some cases to s